AblaCare aims to restore ovulation in PCOS patients through a simple, one-time, durable, minimally invasive treatment. AblaCare's procedure is done transvaginally, under ultrasound guidance, and does not require general anesthesia. The technique can be performed in the clinic setting using the same minimally invasive access commonly used by fertility physicians for IVF.
Location: France, Ile-de-France, Paris
Member count: 1-10
Total raised: $11.258395M
Founded date: 2017
Investors 2
Date | Name | Website |
- | Sofinnova ... | sofinnovap... |
- | MD Start A... | mdstart.eu |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
10.07.2019 | Series A | $11.258395... | - | finsmes.co... |
Mentions in press and media 6
Date | Title | Description | Category | Author | Source |
10.07.2019 | Daily fund... | Perq raised $6 M; Jacobi close... | - | Kristin Ka... | vator.tv/n... |
10.07.2019 | AblaCare R... | AblaCare, a Paris, France-base... | France | - | finsmes.co... |
09.07.2019 | Fierce 15 ... | FierceMedTech Fierce 15 winner... | MedTech | - | fiercebiot... |
09.07.2019 | Fierce 15 ... | FierceMedTech Fierce 15 winner... | MedTech | - | fiercebiot... |
03.10.2018 | Here’s who... | The selection process whittled... | - | - | medcitynew... |
- | Here’s who... | Since 2012, nonprofit startup ... | - | - | medcitynew... |